ICCC
Income statement / Annual
Last year (2023), ImmuCell Corporation's total revenue was $17.47 M,
a decrease of 5.90% from the previous year.
In 2023, ImmuCell Corporation's net income was -$5.77 M.
See ImmuCell Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$17.47 M |
$18.57 M |
$19.24 M |
$15.34 M |
$13.72 M |
$10.99 M |
$10.43 M |
$9.54 M |
$10.23 M |
$7.60 M |
| Cost of Revenue |
$13.08 M
|
$10.92 M
|
$10.59 M
|
$8.48 M
|
$6.98 M
|
$5.79 M
|
$5.21 M
|
$4.12 M
|
$3.98 M
|
$3.15 M
|
| Gross Profit |
$4.40 M
|
$7.65 M
|
$8.66 M
|
$6.86 M
|
$6.74 M
|
$5.19 M
|
$5.22 M
|
$5.42 M
|
$6.25 M
|
$4.45 M
|
| Gross Profit Ratio |
0.25
|
0.41
|
0.45
|
0.45
|
0.49
|
0.47
|
0.5
|
0.57
|
0.61
|
0.59
|
| Research and Development Expenses |
$4.39 M
|
$4.49 M
|
$4.17 M
|
$4.35 M
|
$3.69 M
|
$3.52 M
|
$2.05 M
|
$1.24 M
|
$1.24 M
|
$2.18 M
|
| General & Administrative Expenses |
$2.13 M
|
$2.26 M
|
$1.73 M
|
$1.72 M
|
$1.69 M
|
$1.74 M
|
$1.52 M
|
$1.45 M
|
$1.29 M
|
$1.16 M
|
| Selling & Marketing Expenses |
$3.09 M
|
$5.45 M
|
$4.23 M
|
$3.89 M
|
$4.01 M
|
$3.82 M
|
$3.42 M
|
$1.83 M
|
$1.61 M
|
$1.32 M
|
| Selling, General & Administrative Expenses |
$5.22 M
|
$5.45 M
|
$4.23 M
|
$3.89 M
|
$4.01 M
|
$3.82 M
|
$3.42 M
|
$3.29 M
|
$2.89 M
|
$2.48 M
|
| Other Expenses |
$527,000.00
|
-$187,000.00
|
-$326,000.00
|
$348,000.00
|
-$314,000.00
|
-$413,000.00
|
-$195,000.00
|
-$24,847.00
|
$5,635.00
|
-$3,902.00
|
| Operating Expenses |
$10.14 M
|
$9.95 M
|
$8.40 M
|
$8.24 M
|
$7.69 M
|
$7.34 M
|
$5.46 M
|
$4.53 M
|
$4.13 M
|
$4.66 M
|
| Cost And Expenses |
$23.22 M
|
$20.87 M
|
$18.99 M
|
$16.72 M
|
$14.68 M
|
$13.13 M
|
$10.67 M
|
$8.65 M
|
$8.11 M
|
$7.80 M
|
| Interest Income |
$0.00
|
$153,100.00
|
$18,810.00
|
$27,440.00
|
$118,283.00
|
$14,301.00
|
$16,909.00
|
$54,662.00
|
$19,169.00
|
$15,552.00
|
| Interest Expense |
$0.00
|
$340,878.00
|
$314,359.00
|
$412,687.00
|
$431,788.00
|
$427,782.00
|
$218,571.00
|
$161,697.00
|
$80,235.00
|
$57,827.00
|
| Depreciation & Amortization |
$2.72 M
|
$2.49 M
|
$2.47 M
|
$2.36 M
|
$2.27 M
|
$1.52 M
|
$904,435.00
|
$802,379.00
|
$529,261.00
|
$448,921.00
|
| EBITDA |
-$2.50 M |
$349,990.00 |
$2.72 M |
$1.65 M |
$1.43 M |
$88,442.00 |
$684,529.00 |
$1.72 M |
$2.65 M |
$251,299.00 |
| EBITDA Ratio |
-0.14
|
-0.12
|
0.01
|
-0.09
|
-0.07
|
-0.26
|
-0.02
|
0.18
|
0.26
|
0.03
|
| Operating Income Ratio |
-0.33
|
-0.12
|
-0.11
|
-0.09
|
-0.07
|
-0.13
|
-0.02
|
0.09
|
0.21
|
-0.03
|
| Total Other Income/Expenses Net |
-$21,893.00
|
-$187,190.00
|
-$326,512.00
|
$348,100.00
|
-$313,505.00
|
-$413,481.00
|
-$195,635.00
|
-$131,882.00
|
-$58,774.00
|
-$49,053.00
|
| Income Before Tax |
-$5.77 M
|
-$2.49 M
|
-$69,000.00
|
-$1.03 M
|
-$1.27 M
|
-$1.86 M
|
-$438,000.00
|
$758,322.00
|
$2.06 M
|
-$255,451.00
|
| Income Before Tax Ratio |
-0.33
|
-0.13
|
-0
|
-0.07
|
-0.09
|
-0.17
|
-0.04
|
0.08
|
0.2
|
-0.03
|
| Income Tax Expense |
$4,627.00
|
$8,000.00
|
$9,000.00
|
-$10,000.00
|
$28,000.00
|
$462,000.00
|
-$270,000.00
|
$249,874.00
|
$850,309.00
|
-$88,292.00
|
| Net Income |
-$5.77 M
|
-$2.49 M
|
-$78,000.00
|
-$1.02 M
|
-$1.30 M
|
-$2.32 M
|
-$168,000.00
|
$508,448.00
|
$1.21 M
|
-$167,159.00
|
| Net Income Ratio |
-0.33
|
-0.13
|
-0
|
-0.07
|
-0.09
|
-0.21
|
-0.02
|
0.05
|
0.12
|
-0.02
|
| EPS |
-0.75 |
-0.32 |
-0.0103 |
-0.14 |
-0.19 |
-0.42 |
-0.0339 |
0.12 |
0.4 |
-0.0552 |
| EPS Diluted |
-0.75 |
-0.32 |
-0.0103 |
-0.14 |
-0.19 |
-0.42 |
-0.0339 |
0.12 |
0.38 |
-0.0552 |
| Weighted Average Shares Out |
$7.70 M
|
$7.75 M
|
$7.59 M
|
$7.21 M
|
$6.82 M
|
$5.49 M
|
$4.95 M
|
$4.23 M
|
$3.04 M
|
$3.03 M
|
| Weighted Average Shares Out Diluted |
$7.75 M
|
$7.75 M
|
$7.59 M
|
$7.21 M
|
$6.82 M
|
$5.49 M
|
$4.95 M
|
$4.34 M
|
$3.17 M
|
$3.03 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
